Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

ABSTRACT Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD exacerbations. Methods: This was a systematic review and meta-analysis of randomized clinical trials involving patients...

Full description

Bibliographic Details
Main Authors: Israel Silva Maia, Mariângela Pimentel Pincelli, Victor Figueiredo Leite, João Amadera, Anna Maria Buehler
Format: Article
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia
Series:Jornal Brasileiro de Pneumologia
Subjects:
Pulmonary disease, chronic obstructive
Muscarinic antagonists
Adrenergic beta-agonists
Bronchodilator agents
Aerosol/therapeutic use
Disease management
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017000400302&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017000400302&lng=en&tlng=en

Similar Items